| 000 | 01757 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517154032.0 | ||
| 264 | 0 | _c20180308 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/s13075-017-1306-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThiel, Jens | |
| 245 | 0 | 0 |
_aB cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _c05 2017 |
||
| 300 |
_a101 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis _xdrug therapy |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xpharmacology |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRituximab _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRizzi, Marta | |
| 700 | 1 | _aEngesser, Marie | |
| 700 | 1 | _aDufner, Ann-Kathrin | |
| 700 | 1 | _aTroilo, Arianna | |
| 700 | 1 | _aLorenzetti, Raquel | |
| 700 | 1 | _aVoll, Reinhard E | |
| 700 | 1 | _aVenhoff, Nils | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 19 _gno. 1 _gp. 101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-017-1306-0 _zAvailable from publisher's website |
| 999 |
_c27188834 _d27188834 |
||